Clinical study
Extracranial orbital decompression for optic neuropathy in Graves' eye disease

https://doi.org/10.1016/S0967-5868(98)90036-4Get rights and content

Abstract

Optic neuropathy affects a small proportion of patients with Graves' eye disease. It is due to optic nerve compression by enlarged extraocular muscles and can be treated by corticosteroids, irradiation or surgical orbital decompression. The current report evaluates the effectiveness of extracranial orbital decompression performed by one surgeon for optic neuropathy in Graves' eye disease. The records of 21 patients (33 orbits) undergoing extracranial orbital decompression for Graves' optic neuropathy were analysed for changes in visual acuity and colour vision and reduction in proptosis. Visual acuity and colour vision improved in all 33 eyes in the short-term postoperatively (4 weeks), but later deteriorated in 5 eyes (6.6%) of 4 patients (19%). The remainder maintained improved vision for the duration of the follow-up period (mean 22, range 3–54 months). Proptosis decreased by a mean 5.0 mm (range 1–8). Extraocular muscle imbalance and diplopia worsened in 921 patients (43%) and improved in 221 (9.5%). The patients having medial wall and floor decompressed all had worse diplopia (55), those with medial and lateral wall worsened in 410 cases and improved in 110, and those having all three walls decompressed had no cases of worsening diplopia and 16 improved. All patients with symptomatic diplopia achieved binocular single vision in a useful range after one and sometimes two squint procedures. No patient lost vision as a result of the extracranial orbital decompression, but one lost vision in one eye after transfrontal decompression following failed extracranial decompression. Extracranial orbital decompression is effective in improving vision and reducing proptosis in most patients with optic neuropathy in Graves' eye disease, but induces or worsens diplopia in a high proportion of patients. The diplopia is readily correctable, and the change to decompressions that include the lateral wall may reduce the risk of postoperative diplopia.

Cited by (5)

  • Vertical diplopia and ptosis from removal of the orbital roof in pterional craniotomy

    2015, Ophthalmology
    Citation Excerpt :

    In surgical decompression for thyroid eye disease, bony apertures are left deliberately in the orbital walls. Diplopia and gaze limitation occur in 2% to 43% of cases.18–25 Vertical diplopia and ptosis have been reported in patients with fibrous dysplasia after removal of the orbital roof and lateral wall.26,27

  • Orbital decompression for thyroid eye disease

    2018, Survey of Ophthalmology
    Citation Excerpt :

    Although definition and measurement of DON is widely variable in the literature, authors report rates of improvement DON 75%–90% with inferomedial wall decompression. These results have been described via transcaruncular transorbital,3,104,143,195 transcutaneous transorbital,80 medial transcutaneous transorbital,120 transantral,24,26,65,77,176 and endonasal76,91,162,168 approaches. Management of the periosteum also varies in the literature with descriptions of resection to the apex,143 incision in anterior-posterior direction,76,168 radial incision,24 and nonincisional techniques all leading to improvement in DON.80

  • Dysthyroid Optic Neuropathy

    2018, Ophthalmic Plastic and Reconstructive Surgery
  • Endoscopic orbital and lacrimal surgery

    2014, Bailey's Head and Neck Surgery: Otolaryngology
View full text